🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

GE, General Motors, Verizon rise premarket; Goldman Sachs, Dow fall

Published 25/07/2023, 12:52
© Reuters.
GM
-
DOW
-
GS
-
MMM
-
BIIB
-
WMT
-
VZ
-
GE
-
LOGI
-

Investing.com -- U.S. futures edged higher Tuesday, as investors digest a deluge of corporate earnings ahead of a key Federal Reserve meeting.

Here are some of the biggest premarket U.S. stock movers today:

  • General Motors (NYSE:GM) stock rose 2% after the auto giant lifted its full-year profit guidance, in large part because it plans to invest less in new products and cut operating costs by an additional $1 billion through the end of next year.

  • General Electric (NYSE:GE) stock rose 3.8% after the industrial conglomerate raised its full-year adjusted profit forecast, betting on steady demand for aircraft engine spare parts and services from airlines looking to cash in on surging air travel.

  • Verizon (NYSE:VZ) stock rose 3.1% after the telecoms giant posted a surprise rise in wireless subscriber additions as more users upgraded their mobile phones to access its 5G network.

  • Dow (NYSE:DOW) stock fell 0.7% after the chemicals company reported a lower-than-expected second-quarter profit, hurt by lower prices of its products and weak sales volumes.

  • Goldman Sachs (NYSE:GS) stock fell 0.4% after Citigroup downgraded the investment bank to ‘Neutral’ from ‘Buy,’ saying its targets will take time to be achieved.

  • Walmart (NYSE:WMT) stock rose 1.1% after Piper Sandler upgraded its stance on the retail giant to ‘Overweight’ from ‘Neutral’, saying it can rally more than 30% as it gains grocery market share.

  • 3M (NYSE:MMM) stock rose 2.1% after the industrial conglomerate lifted its full-year EPS guidance even after reporting a quarterly loss as it took a hit from a $10.3 billion settlement related to water pollution claims.

  • Logitech (NASDAQ:LOGI) stock rose 7% after the maker of computer mice and keyboards raised its sales and profit outlook for the first half of the financial year 2024.

  • Biogen (NASDAQ:BIIB) stock rose 1.4% after the biotech said it expects to cut about 1,000 jobs, or about 11% of its workforce, to save costs as the company ramps up the launch of a new Alzheimer's disease drug.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.